世界の白血病治療薬市場2019-2025:種類別(急性骨髄性白血病、慢性骨髄性白血病、急性リンパ性白血病、慢性リンパ性白血病)、用途別、地域別

【英語タイトル】Global Leukemia Therapeutics Market Size Study, by type (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia), by application (Chemotherapy, Radiation Therapy, Targeted Therapy, Biological Therapy, Stem Cell Transplant) and Regional Forecasts - 2019 To 2025

Bizwit Research & Consultingが出版した調査資料(BZW20OC174)・商品コード:BZW20OC174
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2020年10月20日
・ページ数:約150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本市場調査資料では、白血病治療薬の世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、種類別(急性骨髄性白血病、慢性骨髄性白血病、急性リンパ性白血病、慢性リンパ性白血病)分析、用途別(化学療法、放射線治療、標的療法、生物学的療法、幹細胞移植)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・白血病治療薬の世界市場規模:種類別(急性骨髄性白血病、慢性骨髄性白血病、急性リンパ性白血病、慢性リンパ性白血病)
・白血病治療薬の世界市場規模:用途別(化学療法、放射線治療、標的療法、生物学的療法、幹細胞移植)
・白血病治療薬の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Leukemia Therapeutics Market is valued approximately at USD 12500 Million in 2019 and is anticipated to grow with a CAGR of more than 6.0% over the forecast period 2020-2027. Leukemia associated therapeutics targets haematological cancer of blood-forming tissues, inclusive of the blood components and bone -marrow. This condition occurs when bone marrow produces damaged lymphocytes which causes dysfunctional in production of antibodies thus affecting their ability to fight against infection. Rise in geriatric population base and high unmet needs in context with early diagnosis and treatment of Leukemia are the key factors driving the market.

In accordance with the report published by WHO in 2018, globally Leukemia is more prevalent blood cancer in males, 0.0148% men, and 0.009% women worldwide. Also, innovation in drug discovery, rise in volume of biotechnology firms, and increasing investments in the R&D sector are also foreseen to fuel the growth of this market in forecasted period. Furthermore, various government initiatives to promote cancer awareness will fuel the growth of the gloabal Leukemia therapeutic market during forecasted period 2020-2027 Off label prescribing will make treatment more accessible thus leading to growth of the global Leukemia therapeutics market. In addition, presence of limited number of players in market represents a lucrative opportunity for growth of the global Leukemia therapeutic market. However , heavy investment required in research and development seems to restrain the market.

The regional analysis of Leukemia Therapeutic Market is considered for the key regions such as North America, Europe, APAC, MEA, Latin America and rest of the world . North America holds the major market share for Leukemia therapeutics market throughout the coming years followed by Europe owing to the increase in cases of Leukemia and large availability of treatment options. Whereas, the Asia Pacific is foreseen to exhibit highest growth rate / CAGR over the forecast period 2019-2025 due to rising incidence of cancer. China and India are expected to be the fastest growing Leukemia markets in Asia region. Some of the key driving forces for the Leukemia therapeutic market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.

Major market player included in this report are:
Biogen
GSK
Novartis AG
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI Co., Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia

By Application:
Chemotherapy
Radiation Therapy
Targeted Therapy
Biological Therapy
Stem Cell Transplant

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year –2019
Base year – 2019
Forecast period – 2019-2025

Target Audience of the Smart Learning Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2027(USD Million)
1.2.1. Leukemia Therapeutic Market , by Region, 2020-2027(USD Million)
1.2.2. Leukemia Therapeutic Market , by type, 2020-2027(USD Million)
1.2.3. Leukemia Therapeutic Market , by application , 2020-2027(USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Leukemia Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Leukemia Therapeutic Market Dynamics
3.1. Leukemia Therapeutic Market Impact Analysis (2020-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Leukemia Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2020-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Leukemia Therapeutic Market , by type
5.1. Market Snapshot
5.2. Global Leukemia Therapeutic Market by type, Performance – Potential Analysis
5.3. Global Leukemia Therapeutic Market Estimates & Forecasts by type 2020-2027(USD Million)
5.4. Leukemia Therapeutic Market, Sub Segment Analysis
5.4.1. Acute Myeloid Leukaemia
5.4.2. Chronic Myeloid Leukaemia
5.4.3. Acute Lymphoblastic Leukaemia
5.4.4. Chronic Lymphocytic Leukaemia

Chapter 6. Global Leukemia Therapeutic Market , by application
6.1. Market Snapshot
6.2. Global Leukemia Therapeutic Market by application – Potential Analysis
6.3. Global Leukemia Therapeutic Market Estimates & Forecasts by route 2020-2027(USD Million)
6.4. Leukemia Therapeutic Market , Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Radiation Therapy
6.4.3. Targeted Therapy
6.4.4. Biological Therapy
6.4.5. Stem Cell Transplant
Chapter 7. Global Leukemia Therapeutic Market , Regional Analysis
7.1. Leukemia Therapeutic Market , Regional Market Snapshot
7.2. North America Leukemia Therapeutic Market
7.2.1. U.S. Leukemia Therapeutic Market
7.2.1.1. Application breakdown estimates & forecasts, 2020-2027
7.2.1.2. Type breakdown estimates & forecasts, 2020-2027
7.2.2. 2020-2027Canada Leukemia Therapeutic Market
7.3. Europe Leukemia Therapeutic Market Snapshot
7.3.1. U.K. Leukemia Therapeutic Market
7.3.2. Germany Leukemia Therapeutic Market
7.3.3. France Leukemia Therapeutic Market
7.3.4. Spain Leukemia Therapeutic Market
7.3.5. Italy Leukemia Therapeutic Market
7.3.6. Rest of Europe Leukemia Therapeutic Market
7.4. Asia-Pacific Leukemia Therapeutic Market Snapshot
7.4.1. China Leukemia Therapeutic Market
7.4.2. India Leukemia Therapeutic Market
7.4.3. Japan Leukemia Therapeutic Market
7.4.4. Australia Leukemia Therapeutic Market
7.4.5. South Korea Leukemia Therapeutic Market
7.4.6. Rest of Asia Pacific Leukemia Therapeutic Market
7.5. Latin America Leukemia Therapeutic Market Snapshot
7.5.1. Brazil Leukemia Therapeutic Market
7.5.2. Mexico Leukemia Therapeutic Market
7.6. Rest of The World Leukemia Therapeutic Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.3. Biogen
8.4. GSK
8.5. Novartis AG
8.6. Pfizer
8.7. Roche
8.8. Takeda Oncology
8.9. Teva Pharmaceutical
8.10. Celgene
8.11. Daiichi Sankyo
8.12. EISAI Co., Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Leukemia Therapeutic Market , report scope
TABLE 2. Global Leukemia Therapeutic Market estimates & forecasts by region 2020-2027(USD Million)
TABLE 3. Global Leukemia Therapeutic Market estimates & forecasts by type 2020-2027(USD Million)
TABLE 4. Global Leukemia Therapeutic Market estimates & forecasts by route 2020-2027(USD Million)
TABLE 5. Global Leukemia Therapeutic Market estimates & forecasts by facility of use 2020-2027(USD Million)
TABLE 6. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 7. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 8. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 9. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 10. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 11. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 12. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 13. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 14. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 15. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 16. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 17. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 18. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 19. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 20. Global Leukemia Therapeutic Market by segment, estimates & forecasts, 2020-2027(USD Million)
TABLE 21. Global Leukemia Therapeutic Market by region, estimates & forecasts, 2020-2027(USD Million)
TABLE 22. U.S. Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 23. U.S. Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 24. U.S. Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 25. Canada Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 26. Canada Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 27. Canada Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 28. UK Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 29. UK Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 30. UK Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 31. Germany Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 32. Germany Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 33. Germany Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 34. France Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 35. France Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 36. France Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 37. Spain Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 38. Spain Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 39. Spain Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 40. Italy Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 41. Italy Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 42. Italy Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 43. ROE Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 44. ROE Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 45. ROE Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 46. China Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 47. China Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 48. China Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 49. India Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 50. India Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 51. India Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 52. Japan Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 53. Japan Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 54. Japan Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 55. Australia Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 56. Australia Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 57. Australia Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 58. South Korea Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 59. South Korea Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 60. South Korea Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 61. ROPAC Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 62. ROPAC Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 63. ROPAC Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 64. Brazil Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 65. Brazil Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 66. Brazil Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 67. Mexico Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 68. Mexico Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 69. Mexico Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 70. ROLA Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 71. ROLA Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 72. ROLA Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 73. ROW Leukemia Therapeutic Market estimates & forecasts, 2020-2027(USD Million)
TABLE 74. ROW Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 75. ROW Leukemia Therapeutic Market estimates & forecasts by segment 2020-2027(USD Million)
TABLE 76. List of secondary End-Users, used in the study of global Leukemia Therapeutic Market
TABLE 77. List of primary End-Users, used in the study of global Leukemia Therapeutic Market
TABLE 78. Years considered for the study
TABLE 79. Exchange rates considered

List of figures
FIG 1. Global Leukemia Therapeutic Market , research methodology
FIG 2. Global Leukemia Therapeutic Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Leukemia Therapeutic Market , key trends 2019
FIG 5. Global Leukemia Therapeutic Market , growth prospects 2020-2025
FIG 6. Global Leukemia Therapeutic Market , porters 5 force Model
FIG 7. Global Leukemia Therapeutic Market , pest analysis
FIG 8. Global Leukemia Therapeutic Market , value chain analysis
FIG 9. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 10. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 11. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 12. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 13. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 14. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 15. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 16. Global Leukemia Therapeutic Market by segment, 2020 & 2027 (USD Million)
FIG 17. Global Leukemia Therapeutic Market , regional snapshot 2019 & 2025
FIG 18. North America Leukemia Therapeutic Market 2020 & 2027 (USD Million)
FIG 19. Europe Leukemia Therapeutic Market 2020 & 2027 (USD Million)
FIG 20. Asia-Pacific Leukemia Therapeutic Market 2020 & 2027 (USD Million)
FIG 21. Latin America Leukemia Therapeutic Market 2020 & 2027 (USD Million)
FIG 22. Global Leukemia Therapeutic Market , company market share analysis (2019)

★調査レポート[世界の白血病治療薬市場2019-2025:種類別(急性骨髄性白血病、慢性骨髄性白血病、急性リンパ性白血病、慢性リンパ性白血病)、用途別、地域別] (コード:BZW20OC174)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の白血病治療薬市場2019-2025:種類別(急性骨髄性白血病、慢性骨髄性白血病、急性リンパ性白血病、慢性リンパ性白血病)、用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆